Pancreatic Cancer Market

Future Market Insights

Key Insight

The pancreatic cancer market is projected to grow from USD 2.7 billion in 2025 to USD 9.7 billion by 2035, at a CAGR of 13.5%. Chemotherapy will dominate with a 38.5% market share, while exocrine pancreatic cancer will lead the cancer type segment with a 83.0% share.

August 18, 2025

Anurag Sharma

279 Pages

Cite this Report

Pancreatic Cancer Market

https://www.futuremarketinsights.com/reports/pancreatic-cancer-market

License

Starting at US$ 5000

Buy Now

Summary ToC Companies

Key Players

BlackRock
Bristol-Myers Squibb
F. Hoffmann-La Roche Ag
Myriad Genetics
Novartis
PharmaCyte Biotech Inc
Berkshire Hathaway

Methodology

Member of

Greater New York Chamber of Commerce

Recognized by

Awarded by

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

BRONZE STEVIE® Award

20th annual IBAs

Quick Contact

Chat on Whatsapp + 44 20 3769 9709 + 1 347 918 3531 Contact By Email

Get Free Sample PDF

Pancreatic Cancer Market

Key Players

Similar Industry Reports